1482 results
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
Extend your scope of practice beyond traditional roles
21 Nov 2023 – From PCR London Valves 2023
Explore this session to expand your professional horizons within the cath lab, uncovering a spectrum of opportunities, and gain insights into the indispensable role that seasoned nurses and allied professionals assume in supporting the Heart Team throughout transcatheter valve interventions.
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
VitaFlow - The electrically enable self-expanding TAVI valve
21 Nov 2023 – From PCR London Valves 2023
This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.
Facing the challenges of resource shortages - An outlook into the future of TAVI?
21 Nov 2023 – From PCR London Valves 2023
Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...
Best contemporary clinical practice for TAVI
21 Nov 2023 – From PCR London Valves 2023
Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.
Addressing remaining issues after TAVI: what to expect from the new generation?
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.
Rapid-fire - TAVI complications - Part 3
21 Nov 2023 – From PCR London Valves 2023
In this session, delve into challenging scenarios and complications associated with TAVI: navigate the complexities of deploying a balloon-expandable valve in the supra-annular position within severely calcified bicuspid 1B anatomy, discover a case of near-catastrophic annular rupture during TAVI, explore the early days of TAVI in...
Rapid-fire - Combined structural interventions
21 Nov 2023 – From PCR London Valves 2023
Consult this session unraveling the nuances of combined structural interventions, and uncover a unique case of Platypnea-Orthodeoxia syndrome following TAVI, navigate through the complexities of combined TAVR and TMVR in rheumatic heart disease, explore the optimal timing for M-TEER after TAVR in mitral regurgitation, and more!
Rapid-fire - Challenging TAVI procedures - Part 5
21 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI scenarios in this session: experience the challenges posed by a small annulus with anomalous coronary arteries, delve into the Mitroflow Valve-in-Valve TAVR procedure, witness a unique approach to TAVI in a patient with a mechanical mitral valve, and more!
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
Key questions in aortic valve intervention - How to navigate valve sequencing in younger patients?
21 Nov 2023 – From PCR London Valves 2023
What are the aspects to consider when treating younger patients? In this session, get both the interventional cardiologist's and the surgeon's perspective. What do we know and what do we need to know about valve sequencing and hemodynamics? What about CT planning and execution of redo-TAVI?...
PARTNER 3 Low-Risk trial: 5-year insights on TAVI vs. SAVR outcomes
Alex Sticchi interviews Martin Leon about the five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial, presented at the #TCT23 Congress.
The analysis reveals comparable outcomes for TAVI and SAVR, with nuanced differences favouring each approach. Prof. Leon emphasizes the importance of long-term data...
Unmet clinical need & relevance of intermediate & XL sizes in TAVI
08 Jan 2024 – From PCR London Valves 2023
In this roundtable discussion, Patrick Serruys, Andreas Baumbach, and Christian Juhl Terkelsen explore the innovative concept of intermediate sizes and extra-large valves. They introduce a new valve which is another step forward in addressing the unmet needs of the interventional cardiovascular community.
This interview was filmed at...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
